Lung Cancer Trials Supported by the Pharmaceutical Industry More Likely to Report Strong Evidence, Be Open Access
A study of clinical trials found no evidence of bias in the reporting of clinical trials supported by pharmaceutical companies compared with studies that had other funding sources.